Motley Fool Asset Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
Motley Fool Asset Management's DGX Position: Q2 2026 in Review
Motley Fool Asset Management increased its Quest Diagnostics (DGX) stake by 4.2% in Q2 2026, buying an estimated $14.5K and bringing the position to 1,829 shares worth $388K. The position accounts for 0.02% of the portfolio, ranked #201.
Motley Fool Asset Management first reported a position in DGX in Q2 2013 and has held it in 18 quarters since. The position peaked at $1.48M in Q3 2013. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Motley Fool Asset Management held 1,829 shares of Quest Diagnostics worth $388K as of Q2 2026.
- Motley Fool Asset Management bought 74 Quest Diagnostics shares in Q2 2026, an estimated $14.5K.
- Quest Diagnostics made up 0.02% of Motley Fool Asset Management's portfolio in Q2 2026, its #201 holding.
- Motley Fool Asset Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 18 quarters since.
- Motley Fool Asset Management's Quest Diagnostics position peaked at $1.48M in Q3 2013.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Motley Fool Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.